# Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction

Study · id `cardio:ct-nct05487261` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05487261](<https://clinicaltrials.gov/study/NCT05487261>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05487261

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 260 participants.

## Technical summary

Registry record NCT05487261. Randomized; double masking; primary purpose treatment. Start 2022-12-13 (actual); primary completion 2025-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 260 participants (planned count; ClinicalTrials.gov record NCT05487261, source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)
- Started: 2022-12-13 (actual) (ClinicalTrials.gov record NCT05487261, source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)
- Primary completion: 2025-02 (anticipated) (ClinicalTrials.gov record NCT05487261, source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)
- Completion: 2025-11 (anticipated) (ClinicalTrials.gov record NCT05487261, source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT05487261, source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05487261-2023-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
- Acronym: PRESENT-HF
- Condition: Heart Failure
- Intervention (Drug): Sacubitril-valsartan
- Intervention (Drug): Enalapril
- Intervention (Drug): placebo
- Intervention (Drug): Placebo
- Lead sponsor: Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań
- Lead sponsor class: OTHER
- Collaborator: Medical Research Agency, Poland
- Collaborator class: OTHER\_GOV
- Collaborator: Medical University of Bialystok
- Collaborator class: OTHER
- Collaborator: University of Opole
- Collaborator class: OTHER
- Collaborator: Medical University of Gdansk
- Collaborator class: OTHER
- Collaborator: Medical University of Silesia
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Enalapril (`cardio:enalapril`)
- Registry lists this organization as a collaborator: Medical Research Agency, Poland (`cardio:org-medical-research-agency-poland`)
- Registry lists this organization as a collaborator: Medical University of Gdansk (`cardio:org-medical-university-of-gdansk`)
- Registry lists this organization as a collaborator: Medical University of Silesia (`cardio:org-medical-university-of-silesia`)

## Provenance

Content hash: aeec2ab6cd75b2d17920836352776a9d163db9a0e50167927a8065af92eb5e37
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
